Bob A. Rappaport, MD
Dr. Rappaport has 20 years’ experience at the Food and Drug Administration, with the last 12 years as Director of the Anesthesia, Analgesia, and Addiction Products Division at the Center for Drug Evaluation and Research. There he led a large team of physicians, scientists and project managers in the Division that’s expected to review Bridge’s drug candidates. In 2014, he Received the FDA’s Lifetime Achievement Award.
Dr. Rappaport graduated from and completed his medical training at The George Washington University School of Medicine and Health Sciences. He is board certified in neurology and sleep medicine. He is the recipient of numerous awards and has established research initiatives at the FDA in the areas of anesthesia, analgesia, and addiction.
Robert B. Raffa, PhD
Dr. Raffa is Professor Emeritus & Past Chair, Temple University School of Pharmacy (Philadelphia, PA) and Adjunct Professor, University of Arizona College of Pharmacy (Tucson, AZ). Dr. Raffa was a Research Fellow and Team Leader for an analgesics discovery group at Johnson & Johnson and was involved in the elucidation of the mechanism of action of tramadol. He is co-holder of several patents, including the combination of tramadol with acetaminophen.
He has published more than 300 papers in refereed journals, and co-authored or edited several books on pharmacology and thermodynamics, and is a Co-Editor of Journal of Clinical Pharmacy and Therapeutics. He is a past president of the Mid-Atlantic Pharmacology Society and is the recipient of research and teaching awards.
Steven D. Passik, PhD – Clinical Psychology
Dr. Passik is presently the VP of Scientific Affairs, Education and Policy at Collegium Pharmaceuticals. After 25 years in academia and clinical research Dr. Passik transitioned to the pharmaceutical industry to better utilize his knowledge in pain management.
His research has focused on the interface of pain management and addiction and psychiatric aspects of pain symptom management. He has served as editor and reviewer for multiple journals in pain and psycho-oncology. He has authored over 200 scholarly publications on a wide range of medical topics.